After a review of evidence, the UK Health Security Agency (HSA) said today that it no longer classifies clade 1a and 1b mpox ...

Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from a study presented at the Conference on Retroviruses and Opportunistic ...

There were empty seats in San Francisco last week at an annual international science conference which has delivered some of ...

A total of 9% of placebo recipients contracted COVID-19 from a household member, compared with 2.9% of ensitrelvir recipients ...

Elzette Rousseau from the Desmond Tutu Health Foundation told attendees at the top HIV conference in the US about a project ...

Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments.

There were empty seats in San Francisco last week at an annual international science conference that has delivered some of the world's most groundbreaking HIV research. It was a throwback to another ...

In a moment of both triumph and uncertainty, South Africa's scientific community has unveiled encouraging results from a landmark HIV cure trial conducted in Durban, KwaZulu-Natal. The University of ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an ...